Tenax Therapeutics Inc (TENX)

Tenax Therapeutics Inc (TENX) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $50.9M; returns 1 day -2.3%, 1 week +26.5%, 1 year -76.5%.

Tenax Therapeutics Inc. is a specialty pharmaceutical company in the Phase 3 development stage, entirely focused on identifying, developing, and commercializing novel therapies for cardiopulmonary diseases with high unmet medical needs. The company's core asset is its global rights to develop and commercialize levosimendan.

Groups TENX belongs to

• Biotechnology
• Clinical Stage Biotech
• Pharmaceuticals
• Cardiovascular Therapies
• Clinical Stage
• Unmet Medical Needs
• Healthcare
• Life Sciences
• R&D

TENX financial model: income statement, cash flow and balance sheet